Cohort demographics, HIV disease and treatment specifics, and CVD

$ 13.50

4.7 (709) In stock

Cardiovascular and mortality outcomes with GLP-1 receptor agonists

Rochelle P Walensky's research works

Naïve and revised mortality rates by province in (A) all

HIV/AIDS: Differences, Symptoms, Stages, and Treatment

Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel

Robert A. Parker's research works

Trauma Care, Free Full-Text

Characteristics, Prevention, and Management of Cardiovascular

Risk Factors for Coronary Artery Disease: Practice Essentials